<code id='CF41C30B75'></code><style id='CF41C30B75'></style>
    • <acronym id='CF41C30B75'></acronym>
      <center id='CF41C30B75'><center id='CF41C30B75'><tfoot id='CF41C30B75'></tfoot></center><abbr id='CF41C30B75'><dir id='CF41C30B75'><tfoot id='CF41C30B75'></tfoot><noframes id='CF41C30B75'>

    • <optgroup id='CF41C30B75'><strike id='CF41C30B75'><sup id='CF41C30B75'></sup></strike><code id='CF41C30B75'></code></optgroup>
        1. <b id='CF41C30B75'><label id='CF41C30B75'><select id='CF41C30B75'><dt id='CF41C30B75'><span id='CF41C30B75'></span></dt></select></label></b><u id='CF41C30B75'></u>
          <i id='CF41C30B75'><strike id='CF41C30B75'><tt id='CF41C30B75'><pre id='CF41C30B75'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:hotspot    Page View:95358
          Alastair Grant/AP

          LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease drug in a pivotal trial.

          The acquisition includes an upfront payment of $800 million in cash, plus another $250 million if regulatory milestones are met. 

          advertisement

          AstraZeneca framed the deal for Amolyt, which has focused on treatments for rare endocrine diseases, as a boost for its own rare disease pipeline. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          Neuroscience renaissance leads to new crop of psychiatric drugs
          Neuroscience renaissance leads to new crop of psychiatric drugs

          MikeReddyforSTATOnebyone,thecompaniesbehindZoloft,Prozac,andPaxilsouredonpsychiatry.Itwastheearly200

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Childhood vaccination ad campaign launches in the U.K.

          AyoungboyreceivesavaccineatahealthcenterinGlasgow,Scotland.JeffJMitchell/GettyImagesLONDON—Facingagr